DHRDanaher Corp

$163.65
$-0.35 (0%)

Danaher Corp (DHR) Stock Analysis

Create a FREE Account to View Full DHR Stock Report

Danaher Corp (DHR) Analyst Forecast

Next 12 months ➝Current Price$163.6552-week High$169.1952-week Low$110.66MEAN$178.33+8.97%HIGH$195.00+19.16%LOW$162.00-1.01%
  • Last Price$163.65
  • Previous Close$164.00
  • Change $-0.35
  • Open$164.44
  • Volume369,811
  • Avg. Volume (100-day)7,903,636
  • Market Capitalization$113.82B
  • Days Range $163.57 - $164.80
  • 52-week Range $110.66 - $169.19
  • Dividend Yield0.42%
  • Ex. Dividend Date12/26/2019
  • P-E41
  • EPS4.05
  • Earnings Date04/16/2020
  • SectorHealthcare
  • IndustryDiagnostics & Research
  • Avg. Analyst Rec.
  • Beta1.192
  • PEG Ratio2.58
  • Volatility0.39
  • Average True Range0.01
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in four segments: life sciences (33% of 2018 sales), diagnostics (31%), and environmental and applied solutions (22%). In late 2019, Danaher separated from its dental business (14% of 2018 sales) through an initial public offering process and also made plans to acquire GE's Biopharma business, which will add to its life sciences segment.